Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol plus mercaptopurine for liver enzyme reduction in children with acute lymphoblastic leukemia during maintenance
IRCT20240702062309N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of allopurinol in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: AST level, ALT level and 2 more. Started Oct 2022; status: completed.
02
Drugs
allopurinol
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT20240702062309N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240702062309N1.